Viewing Study NCT05627856


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-02-03 @ 11:33 AM
Study NCT ID: NCT05627856
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-26
First Post: 2022-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NK/T Cell Lymphoma View
None Vascular Immunomother T Cell Lymphoma View
None Non-Hodgkin Lymphoma View
Keywords: